KENGREAL is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by The Medicines Company. The primary component is Cangrelor.
Product ID | 65293-003_e16d2568-1d43-420c-a2b4-850f85861271 |
NDC | 65293-003 |
Product Type | Human Prescription Drug |
Proprietary Name | KENGREAL |
Generic Name | Cangrelor |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2015-07-08 |
Marketing Category | NDA / NDA |
Application Number | NDA204958 |
Labeler Name | The Medicines Company |
Substance Name | CANGRELOR |
Active Ingredient Strength | 50 mg/1 |
Pharm Classes | P2Y12 Platelet Inhibitor [EPC],Decreased Platelet Aggregation [PE],P2Y12 Receptor Antagonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2015-07-08 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA204958 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-07-08 |
Marketing End Date | 2019-02-28 |
Marketing Category | NDA |
Application Number | NDA204958 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-07-08 |
Marketing End Date | 2019-02-28 |
Ingredient | Strength |
---|---|
CANGRELOR | 50 mg/1 |
SPL SET ID: | fd5534d0-92c8-41bf-9eca-8259405fbfc2 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
10122-620 | KENGREAL | cangrelor |
65293-003 | KENGREAL | cangrelor |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
KENGREAL 87442665 not registered Live/Pending |
Chiesi Farmaceutici S.P.A. 2017-05-09 |
KENGREAL 86166110 4867615 Live/Registered |
CHIESI FARMACEUTICI S.P.A. 2014-01-15 |